Aisling Capital Lowers stake in Roka Bioscience Inc (ROKA)

Roka Bioscience Inc (ROKA) : Aisling Capital reduced its stake in Roka Bioscience Inc by 10.44% during the most recent quarter end. The investment management company now holds a total of 512,920 shares of Roka Bioscience Inc which is valued at $298,519 after selling 59,800 shares in Roka Bioscience Inc , the firm said in a disclosure report filed with the SEC on May 13, 2016.Roka Bioscience Inc makes up approximately 0.07% of Aisling Capital’s portfolio.

Other Hedge Funds, Including , Cannell Peter B Co Inc reduced its stake in ROKA by selling 2,250 shares or 3.73% in the most recent quarter. The Hedge Fund company now holds 58,098 shares of ROKA which is valued at $33,813.Birchview Capital Lp boosted its stake in ROKA in the latest quarter, The investment management firm added 100,000 additional shares and now holds a total of 252,307 shares of Roka Bioscience Inc which is valued at $171,569. Roka Bioscience Inc makes up approx 0.12% of Birchview Capital Lp’s portfolio.

Roka Bioscience Inc opened for trading at $0.62 and hit $0.7 on the upside on Wednesday, eventually ending the session at $0.65, with a gain of 5.69% or 0.035 points. The heightened volatility saw the trading volume jump to 1,80,860 shares. Company has a market cap of $12 M.

Many Wall Street Analysts have commented on Roka Bioscience Inc. Roka Bioscience Inc was Downgraded by Leerink Partners to ” Mkt Perform” on Mar 7, 2016.

Roka Bioscience Inc. is a molecular diagnostics company. The Company is focused on the development and commercialization of molecular assay technologies for the detection of foodborne pathogens under the Atlas brand name. The Company has launched Atlas Detection Assays and Atlas instrument in the North American food safety testing market and has rights to develop and commercialize its molecular testing solutions for a range of other industrial applications. The detection of foodborne pathogens is accomplished using: culture-based assays immunochemical-based assays and molecular-based assays. The Company’s Atlas instrument is a fully automated molecular diagnostic testing instrument designed to reduce labor costs and operator error in high-volume foodborne pathogen testing laboratories. The Atlas instrument is a sample-in-result-out instrument that eliminates the need for batch processing and automates all aspects of molecular diagnostic testing on a single integrated platform.

Leave a Reply

Roka Bioscience Inc - Is it time to Sell?

Top Brokerage Firms are advising their investors on Roka Bioscience Inc. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.